Hyaluronan hydrogels delivering BMP-6 for local targeting of malignant plasma cells and osteogenic differentiation of mesenchymal stromal cells

Multiple myeloma is a malignant disease characterized by accumulation of clonal plasma cells in the bone marrow. Uncoupling of bone formation and resorption by myeloma cells leads to osteolytic lesions. These are prone to fracture and represent a possible survival space for myeloma cells under treat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Grab, Anna Luise (VerfasserIn) , Seckinger, Anja (VerfasserIn) , Hose, Dirk (VerfasserIn) , Cavalcanti-Adam, Elisabetta A. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 11 July 2019
In: Acta biomaterialia
Year: 2019, Jahrgang: 96, Pages: 258-270
ISSN:1878-7568
DOI:10.1016/j.actbio.2019.07.018
Online-Zugang:Verlag, Volltext: https://doi.org/10.1016/j.actbio.2019.07.018
Verlag: http://www.sciencedirect.com/science/article/pii/S1742706119304982
Volltext
Verfasserangaben:Anna Luise Grab, Anja Seckinger, Patrick Horn, Dirk Hose, Elisabetta Ada Cavalcanti-Adam

MARC

LEADER 00000caa a2200000 c 4500
001 1680038761
003 DE-627
005 20230426084703.0
007 cr uuu---uuuuu
008 191028s2019 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.actbio.2019.07.018  |2 doi 
035 |a (DE-627)1680038761 
035 |a (DE-599)KXP1680038761 
035 |a (OCoLC)1341249370 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Grab, Anna Luise  |e VerfasserIn  |0 (DE-588)1055056084  |0 (DE-627)79259987X  |0 (DE-576)411129287  |4 aut 
245 1 0 |a Hyaluronan hydrogels delivering BMP-6 for local targeting of malignant plasma cells and osteogenic differentiation of mesenchymal stromal cells  |c Anna Luise Grab, Anja Seckinger, Patrick Horn, Dirk Hose, Elisabetta Ada Cavalcanti-Adam 
264 1 |c 11 July 2019 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.10.2019 
520 |a Multiple myeloma is a malignant disease characterized by accumulation of clonal plasma cells in the bone marrow. Uncoupling of bone formation and resorption by myeloma cells leads to osteolytic lesions. These are prone to fracture and represent a possible survival space for myeloma cells under treatment causing disease relapse. Here we report on a novel approach suitable for local treatment of multiple myeloma based on hyaluronic acid (HA) hydrogels mimicking the physical properties of the bone marrow. The HA hydrogels are complexed with heparin to achieve sustained presentation and controlled release of bone morphogenetic protein 6 (BMP-6). Others and we have shown that BMP-6 induces myeloma cell apoptosis and bone formation. Using quartz crystal microbalance and enzyme-linked immunosorbent assay, we measured an initial surface density of 400ng BMP6/cm2, corresponding to two BMP-6 per heparin molecule, with 50% release within two weeks. HA-hydrogels presenting BMP-6 enhanced the phosphorylation of Smad 1/5 while reducing the activity of BMP-6 antagonist sclerostin. These materials induced osteogenic differentiation of mesenchymal stromal cells and decreased the viability of myeloma cell lines and primary myeloma cells. BMP-6 functionalized HA-hydrogels represent a promising material for local treatment of myeloma-induced bone disease and residual myeloma cells within lesions to minimize disease relapse or fractures. - Statement of Significance - Multiple myeloma is a hematological cancer characterized by the accumulation of clonal plasma cells in the bone marrow and local suppression of bone formation, resulting in osteolytic lesions and fractures. Despite recent advances in systemic treatment of multiple myeloma, it is rare to achieve a targeted suppression of myeloma cells and healing of bone lesions. Here we present hydrogels which mimic the physico-chemical properties of the bone marrow, consisting of hyaluronic acid with crosslinked heparin for the controlled presentation of bioactive BMP-6. The hydrogels decrease the viability of myeloma cell lines and primary myeloma cells and induces osteogenic differentiation of mesenchymal stromal cells. The presentation of BMP-6 in the hyaluronan hydrogels enhances the phosphorylation of Smad1/5 while reducing the activity of the BMP-6 antagonist sclerostin. As such, BMP-6 functionalized hyaluronan hydrogels represent a promising material for the localized eradication of myeloma cells. 
650 4 |a BMP-6 
650 4 |a BMP/Smad signaling 
650 4 |a Hyaluronan hydrogel 
650 4 |a Multiple myeloma 
650 4 |a Osteogenic differentiation 
700 1 |a Seckinger, Anja  |d 1980-  |e VerfasserIn  |0 (DE-588)134177371  |0 (DE-627)562118225  |0 (DE-576)278603734  |4 aut 
700 1 |a Hose, Dirk  |d 1969-  |e VerfasserIn  |0 (DE-588)139824995  |0 (DE-627)613790308  |0 (DE-576)313431698  |4 aut 
700 1 |a Cavalcanti-Adam, Elisabetta A.  |d 1972-  |e VerfasserIn  |0 (DE-588)1059179458  |0 (DE-627)798132256  |0 (DE-576)189133511  |4 aut 
773 0 8 |i Enthalten in  |t Acta biomaterialia  |d [Amsterdam] : Elsevier, 2005  |g 96(2019), Seite 258-270  |h Online-Ressource  |w (DE-627)477531210  |w (DE-600)2173841-5  |w (DE-576)255605226  |x 1878-7568  |7 nnas  |a Hyaluronan hydrogels delivering BMP-6 for local targeting of malignant plasma cells and osteogenic differentiation of mesenchymal stromal cells 
773 1 8 |g volume:96  |g year:2019  |g pages:258-270  |g extent:13  |a Hyaluronan hydrogels delivering BMP-6 for local targeting of malignant plasma cells and osteogenic differentiation of mesenchymal stromal cells 
856 4 0 |u https://doi.org/10.1016/j.actbio.2019.07.018  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S1742706119304982  |x Verlag 
951 |a AR 
992 |a 20191028 
993 |a Article 
994 |a 2019 
998 |g 1059179458  |a Cavalcanti-Adam, Elisabetta A.  |m 1059179458:Cavalcanti-Adam, Elisabetta A.  |d 120000  |e 120000PC1059179458  |k 0/120000/  |p 5  |y j 
998 |g 139824995  |a Hose, Dirk  |m 139824995:Hose, Dirk  |d 910000  |d 910100  |d 50000  |e 910000PH139824995  |e 910100PH139824995  |e 50000PH139824995  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 4 
998 |g 134177371  |a Seckinger, Anja  |m 134177371:Seckinger, Anja  |d 910000  |d 910100  |e 910000PS134177371  |e 910100PS134177371  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1055056084  |a Grab, Anna Luise  |m 1055056084:Grab, Anna Luise  |d 910000  |d 910100  |e 910000PG1055056084  |e 910100PG1055056084  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1680038761  |e 3529196967 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title_sort":"Hyaluronan hydrogels delivering BMP-6 for local targeting of malignant plasma cells and osteogenic differentiation of mesenchymal stromal cells","title":"Hyaluronan hydrogels delivering BMP-6 for local targeting of malignant plasma cells and osteogenic differentiation of mesenchymal stromal cells"}],"name":{"displayForm":["Anna Luise Grab, Anja Seckinger, Patrick Horn, Dirk Hose, Elisabetta Ada Cavalcanti-Adam"]},"person":[{"display":"Grab, Anna Luise","given":"Anna Luise","role":"aut","family":"Grab"},{"family":"Seckinger","display":"Seckinger, Anja","given":"Anja","role":"aut"},{"family":"Hose","role":"aut","given":"Dirk","display":"Hose, Dirk"},{"family":"Cavalcanti-Adam","display":"Cavalcanti-Adam, Elisabetta A.","given":"Elisabetta A.","role":"aut"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"11 July 2019","dateIssuedKey":"2019"}],"recId":"1680038761","relHost":[{"language":["eng"],"part":{"pages":"258-270","extent":"13","volume":"96","text":"96(2019), Seite 258-270","year":"2019"},"title":[{"title":"Acta biomaterialia","title_sort":"Acta biomaterialia"}],"pubHistory":["1.2005 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"477531210","origin":[{"publisherPlace":"[Amsterdam]","dateIssuedDisp":"2005-","publisher":"Elsevier","dateIssuedKey":"2005"}],"note":["Gesehen am 09.09.2020"],"disp":"Hyaluronan hydrogels delivering BMP-6 for local targeting of malignant plasma cells and osteogenic differentiation of mesenchymal stromal cellsActa biomaterialia","physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1878-7568"],"zdb":["2173841-5"],"eki":["477531210"]}}],"note":["Gesehen am 28.10.2019"],"id":{"doi":["10.1016/j.actbio.2019.07.018"],"eki":["1680038761"]},"physDesc":[{"extent":"13 S."}]} 
SRT |a GRABANNALUHYALURONAN1120